# IHF is required for the transcriptional regulation of the Desulfovibrio vulgaris Hildenborough orp operons

Anouchka Fiévet, E. Cascales, Odile Valette, Alain Dolla, Corinne Aubert

► To cite this version:

Anouchka Fiévet, E. Cascales, Odile Valette, Alain Dolla, Corinne Aubert. IHF is required for the transcriptional regulation of the Desulfovibrio vulgaris Hildenborough orp operons. PLoS ONE, 2014, 9 (1), pp.e86507. 10.1371/journal.pone.0086507. hal-01458204

HAL Id: hal-01458204

https://hal.science/hal-01458204v1

Submitted on 5 Oct 2018

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>
# IHF Is Required for the Transcriptional Regulation of the *Desulfovibrio vulgaris* Hildenborough *orp* Operons

Anouchka Fiévet¹, Eric Cascales², Odile Valette¹, Alain Dolla¹, Corinne Aubert¹*

1 Laboratoire de Chimie Bactérienne, Institut de Microbiologie de la Méditerranée, CNRS, Marseille, France, 2 Laboratoire d'Ingénierie des Systèmes Macromoléculaires, Institut de Microbiologie de la Méditerranée, CNRS, Marseille, France

## Abstract

Transcriptional activation of σ⁵⁴-dependent promoters is usually tightly regulated in response to environmental cues. The high abundance of potential σ⁵⁴-dependent promoters in the anaerobe bacteria, *Desulfovibrio vulgaris* Hildenborough, reflects the high versatility of this bacteria suggesting that σ⁵⁴ factor is the nexus of a large regulatory network. Understanding the key players of σ⁵⁴-regulation in this organism is therefore essential to gain insights into the adaptation to anaerobiosis. Recently, the *D. vulgaris* *orp* genes, specifically found in anaerobe bacteria, have been shown to be transcribed by the RNA polymerase coupled to the σ⁵⁴ alternative sigma factor. In this study, using *in vitro* binding experiments and *in vivo* reporter fusion assays in the *Escherichia coli* heterologous host, we showed that the expression of the divergent *orp* promoters is strongly dependent on the integration host factor IHF. Bioinformatic and mutational analysis coupled to reporter fusion activities and mobility shift assays identified two functional IHF binding site sequences located between the *orp1* and *orp2* promoters. We further determined that the *D. vulgaris* DVU0396 (IHFα) and DVU1864 (IHFβ) subunits are required to control the expression of the *orp* operons suggesting that they form a functionally active IHF heterodimer. Interestingly results obtained from the *in vivo* inactivation of DVU0396, which is required for *orp* operons transcription, suggest that several functionally IHF active homodimer or heterodimer are present in *D. vulgaris*.

**Citation:** Fiévet A, Cascales E, Valette O, Dolla A, Aubert C (2014) *IHF Is Required for the Transcriptional Regulation of the Desulfovibrio vulgaris Hildenborough orp Operons*. PLOS ONE 9(1): e86507. doi:10.1371/journal.pone.0086507

**Editor:** Fenfei Leng, Florida International University, United States of America

**Received:** July 11, 2013; **Accepted:** December 10, 2013; **Published:** January 21, 2014

**Copyright:** © 2014 Fiévet et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

**Funding:** The Agence nationale de la recherche ANR (ANR-12-ISV8-0003-01) funds this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

**Competing Interests:** Co-author Eric Cascales is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

* E-mail: aubert@imm.cnrs.fr

## Introduction

*Desulfovibrio vulgaris* Hildenborough (DvH) is a well-studied sulfate-reducing bacteria (SRB). It is the first SRB for which the genome has been sequenced [1] and genetics and cellular tools have been recently developed [2]. It is an anaerobic microorganism that exhibits a mode of growth based on the reduction of sulphate as a terminal acceptor and thus is directly linked to natural global sulphur and carbon cycles [3]. These microorganisms have particularly important applications in biotechnology as they are involved in toxic heavy metal bioremediation, hydrogen sulfur decontamination in wastewater and biocorrosion [4]. Although SRBs are ubiquitous in anoxic habitats, they are found in a wide variety of ecological niches as illustrated by their metabolic versatility. Such environmental adaptations require stimuli perception and the subsequent modulation of the expression of relevant genes to optimize metabolism and physiology. Indeed, an unusually large number of response regulators are encoded within the DvH chromosome. Interestingly, 70 potential σ⁵⁴ promoters have been identified by computational prediction [5,6] suggesting that σ⁵⁴ factor is the nexus of a large regulatory network in DvH. The alternative σ⁵⁴ factor associates with the RNA polymerase holoenzyme to target specific genes. However, to proceed to transcription, the σ⁵⁴-RNA polymerase complex requires the action of enhancer binding proteins (EBPs). EBPs usually bind to regulatory sequences

upstream the σ⁵⁴-dependent promoter [7, 8, 9, 10]. Efficient and functional interaction of σ⁵⁴-RNA polymerase with a cognate EBP requires DNA bending, which is often facilitated by the integration host factor (IHF) protein, especially for promoters that lack flexible intrinsic bends [11, 12, 13, 14, 15]. In some cases, IHF has also been shown to recruit the σ⁵⁴-RNA polymerase to its promoter [14]. IHF is involved in many cellular processes correlated with DNA functions such as replication, transcription, partitioning, transfer and packaging into phage particles [11, 16, 17]. Aside its role in specific transcriptional activation of σ⁵⁴ promoters, IHF contributes to a wide variety of macromolecular processes and is recognized, with CRP, FNR, FIS, ArcA, Lrp and H-NS, as one of the seven global regulators in *Escherichia coli* [18,19]. HU, H-NS, FIS and IHF are basic proteins involved in the organization of the DNA nucleoid architecture and are therefore considered as histone-like proteins [20]. In *E. coli* and related bacteria, IHF is a 20-kDa protein composed of two subunits, α and β. Although the αβ heterodimer is the predominant active form, the αα and ββ homodimers might be biologically active [21, 22, 23, 24].

In addition to the 70 putative σ⁵⁴-dependent promoters, DvH genome analyses revealed the presence of 37 putative σ⁵⁴-associated EBPs and several genes encoding IHFα and IHFβ subunits [25]. To date, little is known about the specific roles of σ⁵⁴, the cognate EBPs and IHF in SRBs. Elucidation of their functions is thus essential to generate predictive model of the adaptation, stress responses of SRBs to environmental factors, and
to develop effective SRB-based biotechnologies. In a recent study, we examined the function of the σ⁵⁴-dependent transcriptional regulator DVU2106 in the regulation of the divergent *orp* operons in DvH, which encode proteins putatively involved in positioning the septum in cell division [6]. We showed that this EBP collaborates with the σ⁵⁴-RNA polymerase to orchestrate the simultaneous expression of the *orp* genes cluster [6]. Here, we tested the contribution of IHF to this regulatory mechanism. In a reconstitution assay into the heterologous host *E. coli*, we found that IHF is required for efficient DVU2106-dependent activation of the σ⁵⁴ *orp* promoters. Using electrophoretic mobility gel shift assays, the purified *E. coli* IHF protein was shown to bind to the *orp* promoters. We further localized IHF recognition sites between the σ⁵⁴- and DVU2106-binding sequences and determined which of the three potential IHF binding sites were of physiological relevance using site-directed mutagenesis, reporter fusion activity and *in vitro* gel shifts. We identified DVU0396 (IHFα) and DVU1864 (IHFβ) subunits from DvH as the heterodimer functionally active to complement the transcription of *orp* operons in the IHF-deficient *E. coli* strain. Finally, we tested the role of the IHFα subunit on the transcription of the *orp* operons in DvH.

## Materials and Methods

### Bacterial Strains, Plasmids, Oligonucleotides and Growth Conditions

The bacterial strains and plasmids used in this study are listed in the Table S1. Custom oligonucleotides are listed in the Table S2. *E. coli* strains were routinely grown at 37°C in Luria-Bertani (LB) medium supplemented with the appropriate antibiotic when required (0.27 mM for ampicillin, 0.15 mM for chloramphenicol and 0.20 mM for kanamycin). Cultures of DvH were prepared in Postgate C medium [26] supplemented with 0.17 mM of kanamycin or 0.15 mM of thiamphenicol at 33°C in anaerobic conditions.

### DNA Manipulations

Standard protocols were used for cloning and transformations. All restriction endonucleases and DNA modification enzymes were purchased from New England Biolabs. For electrophoretic mobility shift assay, PCRs were performed using the Expand High Fidelity (Roche Diagnostics). Site-directed mutagenesis was performed using the PfuTurbo® or the PfuUltra™ High Fidelity DNA polymerases (Stratagene). Chromosomal DNA was purified using the Wizard Genomic DNA purification kit (Promega). Plasmid DNA was purified using the High Pure Isolation Plasmid Kit (Roche Diagnostics). PCR products and plasmid fragments were purified using MinElute kits (Qiagen).

### IHF Binding Site Directed Mutagenesis

Site-directed mutagenesis was performed using plasmids pT7.5-*porp2::lacZ*, pT7.5-*pDVU2106::lacZ* and pT7.5-*porp1::lacZ* as templates [6] and specific oligonucleotides carrying mismatches within the putative IHF binding sites. Oligonucleotide pairs 2105IHF-mut-dir/2105IHFmut-rev, 2107IHFmut1-dir/2107IHFmut1-rev and 2107IHFmut2-dir/2107IHFmut2-rev were respectively used to modify the IHF binding sequences of the *orp2* promoter (5'-AAGATGTTTGATT to 5'-CCGATGTTTGGGT), the IHF binding sites 1 (5'-AATCAGAATAAAA to 5'-GGGCAGAA-TACCC) and 2 (5'-CATCACAAGCTCG to 5'-CGGGA-CAAGCCCC) of the *orp1* promoter. After PCR amplification of the whole plasmids, the methylated templates were eliminated by *Dpn*I digestion and mutated plasmids were recovered by transformation

into *E. coli* DH5α competent cells. The accuracy of the mutagenesis has been verified by DNA sequencing.

### Expression Plasmids

For plasmids producing DvH IHFα, IHFβ and IHFα+β, the strong and constitutive *lpp* promoter was PCR amplified from *E. coli* K12 genomic DNA and cloned into the pOK12-2106 vector [6] downstream the *DVU2106* gene using the unique *EcoRI* and *Nde*I restriction sites, yielding pOK12-2106-lpp. The IHFα-encoding *DVU0396* or IHFβ-encoding *DVU1864* genes were PCR-amplified from DvH genomic DNA and cloned downstream the *lpp* promoter in pOK12-2106-lpp using the unique *Nde*I and *Not*I restriction sites to yield pOK12-2106-lpp-0386 and pOK12-2106-lpp-1864 respectively. For construction of the plasmid carrying both genes, *DVU0396* was PCR-amplified and cloned downstream DVU1864 using the *Not*I restriction site resulting in pOK12-2106-lpp-1864-0396.

### Strain Construction

The W3110 *ΔlacZ ΔihfA E. coli* strain was constructed by P1 transduction from the BW25113 *ihfA::kanR* strain from the KEIO collection [27] and cassette excision using pCP20 as previously described [28] using W3110 *ΔlacZ* as recipient [29]. The DvH *Δihfα* mutant strain was constructed using previously described protocols [30,31]. Briefly, the 455-pb fragment upstream the *DVU0396* gene was PCR-amplified using oligonucleotides DVU0395*AscI_dir* and *CterDVU0395-SpeI* and cloned into the *AscI* and *SpeI* sites of plasmid pDel. The 460-pb fragment downstream *DVU0396* was PCR-amplified using oligonucleotides DVU0396*MfeI_dir* and DVU0396*BglII_rev* and cloned into *MfeI* and *BglII* sites of the plasmid previously constructed to yield pDelihfα. The accuracy of the cloned fragments was verified by restriction and DNA sequencing. The pDelihfα plasmid was transferred into DvH cells by electroporation as following: DvH cells grown in PC medium were harvested at early stationary phase (OD₆₀₀~0.8-1) and washed twice with cold and degassed sterile MilliQ-water. Approximately 500 ng of the pDelihfα plasmid were electroporated with a single 1.9 KV, 25 µF and 250 Ω pulse into DvH competent cells in BTX 1-mm gapped cuvette using a BTX Harvard Electro Cell Manipulator® ECM630 apparatus. Cells were recovered in 30 ml of PC medium, and the culture was supplemented with 20 µg/ml of thiamphenicol after 6 hours of incubation at 33°C. After 7 days of culture in the same conditions, the culture was diluted in PC medium supplemented with thiamphenicol. After three rounds of culture and dilution, individual colonies were recovered by plating on PE medium supplemented with thiamphenicol. The deletion of the *ihfα* gene was verified by colony-PCR.

### RNA Preparation

DvH was grown in three 80-ml independent cultures of DvH to an OD₅₀₅~0.4. The cells were harvested and resuspended in 200 µl of 10 mM Tris pH8. RNA was prepared by using the High Pure RNA kit (Roche Diagnostics) according to the manufacturer's instructions with an additional DNase I digestion step.

### Real-time Quantitative PCR

10 µg of total extracted RNA were reverse transcribed by using random hexamers to yield cDNA. Real-time PCR was performed on a LightCyclerFastStart DNA MasterPLUS SYBR Green I Kit (Roche Diagnostics). cDNA was mixed with 0.25 µM of each primer and 2 µl of master mix in a 10 µl final volume. The primers pairs used to quantify the expression levels of the selected
genes are shown in Table S2. PCR amplifications were carried out with one cycle at 95°C for 8 min, followed by up to 45 cycles at 95°C for 12 s, 60°C for 6 s and 72°C for 20 s. The specificities of accumulated products were verified by melting-curve analysis. The fluorescence derived from the incorporation of SYBR Green I into the double-stranded PCR products was measured at the end of each cycle to determine the amplification kinetics of each product. The fit points method described by the manufacturer was then applied to the results. Briefly, a horizontal noise band was determined as well as a log line fitting the exponential portion of the amplification curve. The intersections of these log lines with the horizontal noise lines identified the crossing points. These crossing points were determined for each gene in three conditions. Relative Expression Software Tool (REST) was used to calculate the relative expression of each gene in each condition using the 16S RNA gene as reference for normalization.

## β-galactosidase Assay

The activity of the β-galactosidase reporter was measured from mid-exponential growth phase cultures (OD~600~0.8) as previously described [32]. Each enzymatic assay was performed in triplicate with three independent biological samples. The values are reported as the average of these nine measurements.

## Purification of the *E. coli* IHF Heterodimer

E. coli MC4100 pTrc-IHF [33] was grown overnight in 10 ml of LB supplemented with kanamycin at 37°C with shaking and used to inoculate 1 liter of LB. This culture was grown until the OD~600~ reached 0.6, and 1 mM of IPTG was then added. After 3H of induction, the E.coli IHF heterodimer was extracted as described [33]. Briefly, cells were washed with 40 ml of Buffer E (25 mM Tris-HCl pH7.4, 1 mM EDTA, 3 mM β-mercaptoethanol, 100 mM NaCl, 1 mM PMSF and 10% glycerol). After centrifugation, cells were resuspended in 10 ml of Buffer E supplemented with DNase. Cells were broken by 3 passages in French-press and centrifugated at 45000 rpm during 1 H at 4°C. IHF heterodimer was then purified by two consecutive steps: immobilization onto a HiTrap Heparin HP column equilibrated in Buffer E and elution with a step gradient of KCl (0.2 M–2 M). The fractions containing IHF (0.8 to 1.2 M KCl) were pooled and diluted in Buffer A (25 mM Tris-HCl pH7.4, 1 mM EDTA, 3 mM β-mercaptoethanol and 10% of glycerol) to obtain a final KCl concentration of 100 mM, immobilized onto a HiTrap SP FF column and eluted with a step gradient of KCl. The fractions containing the IHF heterodimer (500–600 mM of KCl) were pooled and the buffer was exchanged against Buffer A. The final concentration of IHF was ~1.5 mg/ml.

## Electrophoretic Mobility Shift Assay (EMSA)

³²P-labeled probes were obtained by PCR amplification using a dNTP mix supplemented with [α-³²P]-deoxyadenosine triphosphate and plasmid DNA as template. Labeled probes were column-purified to remove radioactive nucleotides (PCR Clean-up, Promega). For gel shift experiments, ³²P-labeled probes were mixed with different concentration of purified IHF in a binding reaction mixture containing sonicated salmon sperm DNA (10 µg/mL UltraPure™, Invitrogen) and Bovine Serum Albu-mine (200 µg/mL Fraction V, Sigma Aldrich) in 40 mM Tris-HCl pH7.5, 50 mM NaCl, 40 mM NH₄Cl, 5 mM MgCl₂, 1 mM CaCl₂, 8% glycerol, and 1 mM dithiothreitol (DTT). After incubation during 20 min at room temperature, DNA and DNA complexes were separated on a prerun 5,5% polyacrylamide (acrylamide:bis-acrylamide 29:1) gel supplemented with 10% triethylene glycol [34] in Tris-Borate buffer. Gels were fixed in

10% trichloroacetic acid for 10 min and exposed to Kodak BioMax MR films.

## Results

### IHF is Required for *orp1* and *orp2* Transcription

It was previously shown that the two divergent *orp* operons require the σ⁵⁴ RNA polymerase and the cognate transcriptional EBP, DVU2106, to achieve transcription [6]. It is well described that DNA bending allowing contacts between the cognate activator and σ⁵⁴-RNA polymerase to activate transcription is usually facilitated by the heterodimeric IHF protein. To test the contribution of IHF to the expression of these genes, the previously described *orp1*, *orp2* and *DVU2106* promoter-*lacZ* transcription fusions were introduced into the heterologous host *E. coli*. Expression of these promoter-*lacZ* fusions were examined in both IHF-proficient (wild-type) and IHF-deficient (ΔihfA) strains that produced the transcriptional regulator DVU2106 from a compatible multicopy plasmid (Figure 1A–D). The expression of *DVU2106*, controlled by the σ⁷⁰-RNA polymerase, was not influenced by the absence of IHF (Figure 1C). By contrast, the activities of the *orp1* and *orp2* promoters, under the control of the σ⁵⁴-RNA polymerase, were significantly affected by the absence of IHF as the *orp1*::lacZ and *orp2*::lacZ expression levels decreased 10–12 fold compared to the wild-type strain producing IHF (Figure 1B and 1D). These results show that the *E. coli* IHF heterodimer can activate *orp* operons transcription and that IHF is required for the expression of these σ⁵⁴-dependent operons.

<figure><img src="image_2.png" /><figcaption>**Figure 1.** IHF is involved in the transcriptional activation of both operons *orp1* and *orp2*. (A) Schematic representation of the transcriptional elements of promoter regions of *orp1*, *DVU2106* and *orp2*. The positions of the σ⁵⁴ and σ⁷⁰ promoters are indicated by bent arrows and the DVU2106-binding sites are indicated by solid line boxes. The *lacZ* reporter fusions with the promoter regions of *orp1* (B), *DVU2106* (C) and *orp2* (D) are represented on the left. The transcript start sites are indicated by bent arrows. The positions of the -10 and -35 sequences of the σ⁷⁰ promoter and the -12 and -24 sequences of the σ⁵⁴ promoters are indicated by black rectangles. The activities measured in various backgrounds are shown on the right: *E.coli* wild-type strain (dark-grey) and *E.coli ΔihfA* strain (light-grey). The activity is the average of three independent measurements (the error bars show the standard deviations).</figcaption></figure>

doi:10.1371/journal.pone.0086507.g001
The *E. coli* IHF Protein Binds to the Promoter Regions of *orp1* and *orp2*

To address whether IHF can bind to these promoters, we
carried out electrophoretic mobility shift assays (EMSA). ³²P-
labeled *orp1* and *orp2* promoter fragments were incubated with
increasing concentrations of purified *E. coli* IHF heterodimers. As
shown in Figure 2, the two DNA fragments were specifically
retarded in presence of ≥4 nM of IHF. These data demonstrate
that the IHF protein interacts with the promoter regions of the
*orp1* and *orp2* operons.

Identification of the Functional IHF Binding Sites

*In silico* analyses of the intergenic region of the *orp* cluster using the Virtual Footprint program (http://prodoric.tu-bs.de/vfp/vfpPromoter.php) suggested the presence of two potential IHF binding sites within the *orp1* promoter (called hereafter IHF1 and IHF2) located at positions -42 and -79, respectively, from the transcriptional start site of *orp1* (Figures 3 and S1) and one potential binding site for IHF within the *orp2* promoter, located at position -43 from the transcriptional start site of *orp2* (Figures 3 and S1). The *orp1* IHF1 site (**AATCAGAATAAA**) [conserved nucleotides are in bold]) has 78% similarity with the reported *E. coli* consensus sequence with the conserved nucleotides mainly located at the 5' extremity of the sequence whereas the *orp1* IHF2

<figure><img src="image_3.png" /><figcaption>**Figure 2.** The integrator Host Factor (IHF) interacts with the promoter regions of *orp1* and *orp2*. Shown is the gel shift assay of the promoter regions of *orp1* (A) and *orp2* (B) using purified *E.coli* IHF heterodimer (lane 1, no protein; lane 2, 4 nM; lane 3, 8 nM; lane 4, 12 nM; lane 5, 16 nM).

*doi:10.1371/journal.pone.0086507.g002*</figcaption></figure>

site (*CATCACAAGCTCG*) shares less similarity (67%) but better
distributed throughout the sequence (Figures S1 and S3). The *orp2*
potential IHF site (*AATCAAACATCTT*) has 78% similarity with
the reported *E. coli* consensus sequence. Regarding the relative
position of these IHF binding sites compared to those of σ⁵⁴ and of
DVU2106, the *orp1* IHF1 (−42) and IHF2 (−79) sites are located
upstream the σ⁵⁴-binding sequence (position −13) and down-
stream the EBP binding site (position −131) (Figure S1). The *orp2*
IHF binding site (−43) is located upstream the σ⁵⁴-binding
sequence (position −11) and downstream the EBP binding site
(position −88) (Figure S1). Therefore, the locations of the three
potential IHF binding sites are centred between σ⁵⁴- and
DVU2106-binding sequences.

To determine the contribution of these IHF binding sites to the
transcriptional activities of the *orp1* and *orp2* promoters, each of
these consensus sites was altered by generating mutations at bases
previously reported to be necessary for IHF binding [35] yielding
*orp1* IHF1-mut, *orp1* IHF2-mut and *orp2*-IHF-mut and DVU2106-
IHF-mut (*DVU2106* promoter region in which *orp2* IHF site was
mutated) (Figure S2). These mutations were introduced into
plasmids carrying promoters-*lacZ* transcription fusions. As done
previously, expression of the wild-type and mutated promoter-*lacZ*
fusions were compared in the IHF-proficient (wild-type) and IHF-
deficient (ΔihfA) strains that produced the transcriptional regulator
DVU2106 from a compatible multicopy plasmid. The accumu-
lation of β-galactosidase was measured and reported in Figure 4.
The expression of *orp1* was not significantly affected by the
mutation within the IHF1 site, as 98% of the β-galactosidase
activity was retained compared to the IHF proficient strain with
native *orp1*'-:lacZ fusion (Figure 4A). By contrast, the β-galactosi-
dase activity decreased to 8% of the activity of the wild-type
promoter when the IHF2 site was altered (Figure 4B), a value
similar to that of the wild-type reporter fusion in an IHF-deficient
strain (compare Fig. 4B and Fig. 1B). When both sites were
altered, the residual activity of the *orp1* promoter was comparable
to that observed with the single IHF2 site mutation (Figure 4C).
Regarding the expression from the *orp2* promoter, mutation of the
potential IHF site led to a 10-fold decreased β-galactosidase
activity compared to the wild-type reporter fusion (Figure 4E).
Here again, this activity is comparable to that of the wild-type

<figure><img src="image_4.png" /><figcaption>**Figure 3. Sequence analyses of the orp1 and orp2 promoter regions.** (A) The σ⁵⁴ and σ⁷⁰ promoters of the ORP system are indicated by bent arrows. The solid-line boxes indicate the palindromic DVU2106-binding sites. The dashed boxes represent the three putative IHF-binding sequences identified by comparison to the consensus sequence of the *E.coli* IHF-binding site (5'-WATCARxxxxTTR-3'). (B) DNA sequence alignment between the consensus sequence of *E.coli* IHF-binding site and each putative IHF-binding sequence of *orp1* and *orp2* promoter regions. The sequence identity between the consensus sequence of the *E.coli* IHF-binding site and the different *orp* putative IHF-binding site are indicated in bold.

*doi:10.1371/journal.pone.0086507.g003*</figcaption></figure>
fusion in IHF-deficient cells (compare Fig. 4E and Fig. 1D). The expression of *DVU2106*, controlled by σ⁷⁰-RNA polymerase, was not influenced by the absence of IHF protein and by the disruption of the *orp2* IHF site (Figure 4D). These results demonstrate the requirement of the *orp1* IHF2 and *orp2* IHF sites for the efficient transcription of the σ⁵⁴-dependent *orp1* and *orp2* promoters, respectively. These results further suggest that these sites could be targets for IHF binding.

To address whether IHF binds to these putative IHF binding sites, we carried out EMSA experiments with increasing concentrations of the purified *E. coli* IHF protein and ³²P-labeled *orp1* and *orp2* mutated promoters. In agreement with the β-galactosidase activities, figure 5 shows that disruption of the *orp1* IHF1 site did not prevent formation of the IHF-DNA complex (Figure 5A) whereas mutation within the IHF2 site (or within both IHF1 and IHF2 sites) abolished IHF binding (Figure 5B and 5C). Similarly, alteration of the *orp2* IHF site significantly prevented IHF binding to the *orp2* intergenic region (Figure 5D). It should be noted that 8 nM of IHF are needed for observing the formation of the IHF/*orp1* IHF2 complex when the *orp1* IHF1 site is altered (Figure 5A) whereas only 4 nM of IHF are necessary to form the same complex when *orp1* IHF1 is not altered (Figure 2A) suggesting that *orp1* IHF1 might promote binding of IHF on the IHF2 site.

Taken together, these results demonstrate that the *orp1* IHF2 site is required for IHF binding and *orp1* transcription and the *orp2* IHF site recruits IHF to activate *orp2* transcription. It is noteworthy that the purified IHF protein binds to sites centred between DVU2106 binding sites and σ⁵⁴ promoters in both

<figure><img src="image_5.png" /><figcaption>**Figure 4.** *orp1* IHF-2 and *orp2* IHF sites are involved in transcriptional activation of *orp1* and *orp2*, respectively. The *lacZ* reporter fusions with the promoter regions of (A) *orp1* IHF1-mut, mutated for the putative IHF-binding site 1, (B) *orp1* IHF2-mut, mutated for the putative IHF-binding site 2, (C) *orp1* IHF-mut, mutated for both IHF-binding sites, (D) DVU2106 IHF-mut, mutated for putative IHF-binding site of *orp2* promoter and (E) *orp2* IHF-mut, mutated for the putative IHF-binding site are represented on the left. The nature of these mutations is described in materials and methods and in figure S4. Promoters σ⁵⁴ and σ⁷⁰ are indicated by bent arrows. The putative IHF-binding sites are indicated by boxes: solid-line boxes for wild-type sites and dashed boxes for mutated sites. The activities measured in various backgrounds are shown on the right: *E.coli* wild-type strain (dark-gray) and *E.coli* Δ*ihfA* strain (light-gray). The measures shown in black and indicated by (+) correspond to the β-galactosidase activity observed in a wild-type *E.coli* strain carrying the fusion between wild-type promoters and *lacZ*. The activity is the average of three independent measurements (the error bars show the standard deviations).
doi:10.1371/journal.pone.0086507.g004</figcaption></figure>

<figure><img src="image_6.png" /><figcaption>**Figure 5.** The integrator Host Factor (IHF) interacts with the site 2 of promoter region of *orp1* and the putative IHF binding site detected in *orp2*. Shown is the gel shift assays of the promoter regions of (A) *orp1* IHF1-mut, (B) *orp1* IHF2-mut, (C) *orp1* IHF-mut and (D) *orp2* IHF-mut, using purified *E.coli* IHF (lane 1, no protein; lane 2, 4 nM; lane 3, 8 nM; lane 4, 12 nM; lane 5, 16 nM). Lane 6 is from Figure 2 and corresponds to the gel shift assays of wild-type promoter fragments using 16 nM of purified *E.coli* IHF.
doi:10.1371/journal.pone.0086507.g005</figcaption></figure>

operons, a result compatible with IHF function in DNA bending to facilitate contacts between the distantly-located EBP and σ⁵⁴-RNA polymerase.

## The DvH DVU0396-DVU1864 Heterodimer is Functionally Active to Stimulate the Transcription of the *orp* Operons

IHF is usually described as a heterodimeric protein complex composed of the IHFα and IHFβ subunits encoded by the *ihfA* (*himA*) and *ihfB* (*himB*) genes. Genome analyses of various species known to encode active heterodimeric IHF revealed the presence of a single copy of genes encoding IHFα and IHFβ, found at distinct locations on the chromosome and subject to independent regulatory influences [36]. Surprisingly, two orthologs of *himB*, DVU1864 and DVU2973 that would encode IHFβ, are annotated on the DvH genome. Amino acid sequences of DVU1864 (called here β1) and DVU2973 (called here β2) are 65% identical together and respectively 42% and 45% identical to the *E. coli* IHFβ (Figure 6). By contrast, no gene encoding IHFα was annotated whereas six orthologs of *hup* genes encoding HU proteins were detected. Nevertheless, it has been previously proposed that two of the putative HU-encoding genes, *DVU0396* and *DVU0004*, correspond to *himA* that encodes the
HUβ:

DVU1864 MNKSELIRTSEETN------IPIEEATIVVNT 27
DVU2973 MNKSELVKMLAENHE------IPAEESSVIVNL 27
DVU1134 MNRKELVSAVQNTLERTGCKITRRDVERTLDV 32
**:**:**:** : : : * . : : :

DVU1864 FIDNMKDSLLAGDRVEIRGFGSFKIKDYGGYS 59
DVU2973 FFDSVRDALLQGDRVEIRGFGSKVKGYRGYK 59
DVU1134 FGDVAAAELLEGGDVPLPVLGKLRSVERAARA 64
* * ** * . * : *.*: : .

DVU1864 GRNPKTGKMVDEPKRLPFFRAGKELKEFLNE 91
DVU2973 GRNPKTGDNVEPPKRLPVFRAGKELKEIINP 91
DVU1134 GRNPRTGESIAIPARRVTVFKAGKDLREALG- 95
*****:**. : : .:*: *:**:**:* : .

DVU1864 QQ 93
DVU2973 -- 91
DVU1134 -- 95

IHFα

DVU0396 MSKTLTKAEIVDAIYE---KTDRNRAEVKGVV 29
DVU0764 ----MTKAELVEKIHA--KAGLATKAQAESAL 26
DVU1795 ---MTKADLVDKIAA--KANL-TKASAERSL 25
DVU3187 ---MLTKAEFVAALKDSLPDVFETKVSAEKAY 29
:***:** : . . . .

DVU0396 ESLLGIMKQAIKDHALLISGFGKFEAYDKKA 61
DVU0764 DATIAVLADAMAAGESVTFTGFGSFKVADRAA 58
DVU1795 NAFLDAVKDVLASEGKLTLTGFGTFAVESRQE 57
DVU3187 DTFCKIMADGVANGQGVRLPGVGALTVTERAA 61
: : : : : : .*.* : . . :

DVU0396 RKGRNPQTDETITLPPRKVVVFRLSRKFRAEL 93
DVU0764 RKGRNPRTGEEIVIPAGKVVKFTPGKLLKDAV 90
DVU1795 RKGRNPRTGAEIKIPASKVVKFRPGKTLKDAV 89
DVU3187 RTGRNPQTGQTITIPARKAVKFAAAKALLDGI 93
.*.*.*:**. * : .*.* * . : : :

DVU0396 NE 95
DVU0764 K- 91
DVU1795 K- 90
DVU3187 NG 95
:

**Figure 8. Protein sequence alignment of putative IHFβ and IHFα subunits from DvH.** The figure shows the sequence of DVU1864 aligned with the sequences of the two putative IHFβ from DvH, DVU1864 and DVU2973 and the sequence of DVU0396 (IHFα) aligned with the sequences of three putative IHFα from DvH using ClustalW (http://www.ebi.ac.uk). Highlighted residues correspond to crucial amino-acids for IHF function in *E. coli*. doi:10.1371/journal.pone.0086507.g008

Discussion

In most environments, microorganisms are under tough competition for available resources and have to perceive, integrate and respond to multiple signals pertaining to a variety of stresses that include limited nutrient availability, physicochemical stresses and pollutant toxicity. The ability to appropriately adapt to prevailing conditions usually involves complex regulatory mechanisms such as two-component systems and σ⁵⁴-dependent

<figure><img src="image_7.png" /></figure>

**Figure 9. Schematic representation of the regulatory mechanisms of the *orp* gene cluster in DvH.** The positions of the σ⁵⁴ and σ⁷⁰ are indicated by bent arrows, the DVU2106-binding sequences are indicated by hatched rectangles and IHF-binding sequences are indicated by blotted rectangles. The DVU2106 transcriptional regulator and IHF play a positive role in the expression of the σ⁵⁴-dependent *orp1* and *orp2* operons. DVU2106 exerts a negative retrocontrol on its own σ⁷⁰-dependent expression.
doi:10.1371/journal.pone.0086507.g009

promoters. In addition to the σ⁵⁴ alternative factor, the σ⁵⁴ pathway requires enhancer binding proteins and DNA bending. EBP5 interact with an upstream activating sequence, and through DNA looping, which can be facilitated by IHF, contact the σ⁵⁴-RNA polymerase. Interestingly, a large number of potential σ⁵⁴-promoters and EBP5 have been identified in DvH, an observation in accordance with the high metabolic versatility of this species [2]. To date nothing is known on the role of IHF in this bacterium and more particularly on its contribution to the σ⁵⁴ regulatory mechanism. We recently showed that two gene operons, *orp1* and *orp2*, are regulated by σ⁵⁴ and a cognate EBP, DVU2106 [6]. In this study, we have refined the regulatory mechanism underlying *orp* gene expression by demonstrating that IHF contributes to the regulation of these genes.

Using an *in vivo* reconstitution approach in *E. coli*, we showed that the activities of the divergently transcribed *orp1* and *orp2* operon promoters require the integration host factor IHF. Although the predominant role of IHF is to facilitate contacts between the EBP and the σ⁵⁴-RNA polymerase, it was shown in *P. putida* that IHF is also important to recruit the σ⁵⁴-RNA polymerase to its promoter [14]. The low expression of the *orp* operons measured in absence of IHF and the location of the IHF binding sites, located between the DVU2106 EBP- and the σ⁵⁴-binding elements suggest a direct role of IHF to assist in the formation of direct contacts between DVU2106 and the RNA polymerase and/or to recruit the σ⁵⁴-RNA polymerase to the appropriate site [38,39,40]. The activities of the *orp1* and *orp2* promoters were reduced 10–12 fold in absence of IHF or when IHF-binding boxes were altered, probably reflecting the limitations imposed by the absence of IHF-induced DNA bending. In several instances, IHF has been shown to be dispensable for σ⁵⁴-dependent regulation; however, in these cases, DNA bending is induced by stretches of A/T-rich sequences between σ⁵⁴- and EBP-binding elements [35,41]. No A/T-rich region that may induce natural curvature of DNA is found between the DVU2106- and the σ⁵⁴-binding sites of *orp1* and *orp2* (Figure S1), an observation that may explain the important requirement for IHF for the regulation of the *orp1* and *orp2* operons. Such drastic effect was observed for the *TodS-TodT* two-component regulatory system from *P. putida* in which the absence of IHF causes a 8-fold decrease of the *todX* promoter expression compared to the wild-type strain [38].

It is noteworthy that these assays have been performed in the heterologous host *E. coli*. The fact that the absence of the *E. coli* IHF causes a decreased in expression of the *orp1* and *orp2* promoters demonstrates that despite the weak homology between the *E. coli* and DvH proteins, they are functionally similar. We
therefore took advantage of this observation to (i) use the purified *E. coli* IHF protein for *in vitro* studies and (ii) to identify the DvH functional IHF heterodimer in reconstitution experiments in the *E. coli* Δ*ihfA* strain.

The *E. coli* IHF protein was purified and electrophoretic mobility shift experiments using *orp1* and *orp2* promoter probes showed that, as expected from the IHF requirement for transcriptional activation, IHF binds to both promoters. We therefore went further by identifying the IHF binding sequences within the *orp1* and *orp2* promoters using a combination of computational and mutational analyses coupled to mobility shift and promoters-*lacZ* transcription reporter fusion assays. Bioinformatic analyses revealed the presence of two putative IHF boxes upstream the *orp1* σ⁵⁴ promoter and one upstream the *orp2* σ⁵⁴ promoter. We showed that IHF binds the *orp1* IHF2 and the *orp2* IHF binding sequences. The results from the transcriptional reporter fusions were consistent with these data as alteration within the *orp1* IHF1 site has no effect on the expression level, whereas alterations within the *orp1* IHF2 or *orp2* IHF sites decrease the expression to levels comparable to that of the wild-type promoters in the Δ*ihfA* strain. Therefore, the *orp1* IHF2 and *orp2* IHF binding site are required for IHF-mediated activation of the *orp1* and *orp2* promoters respectively. It is worth to note that *orp1* expression is mediated by the IHF2 site and not IHF1. This result is, at first, surprising because comparison of these sequences with the *E. coli* IHF binding consensus motif shows that the *orp1* IHF2 site is less conserved than IHF1 (67% and 78% respectively, Figure S3) and the 5' of the IHF1 sequence is 100% identical to the reported consensus (WATCAR) whereas the IHF2 sequence is less conserved in this region (Figure S3).

An *in vivo* reconstitution approach in *E. coli* allowed us to identify DVU0396 (IHFα) and DVU1864 (IHFβ) as a functionally active heterodimer able to fully complement the absence of the *E. coli* IHFα subunit. By contrast, DVU0396 alone is unable to complement for the absence of the *E. coli* IHFα subunit and to functionally interact with the *E. coli* IHFβ contrarily to what has been described for *P. putida* IHFα [42]. This could be explained by the difference between the similarities of *E. coli* IHFα and DvH DVU0396 (32%) or *P. putida* IHFα (86%). The fact that DVU0396 and DVU1864 assemble a functionally active heterodimer is in agreement with recent results demonstrating that DVU1864 interacts preferentially with DVU0396 in pull-down experiments [36]. While expression of the *orp* operons is on the same order of magnitude in the presence of *E. coli* IHF and DvH DVU0396/DVU1864 heterodimer, it will be interesting in the future to test DVU0396/DVU1864 binding on the *orp* promoters by EMSA. Experiments are currently underway to purify the DvH DVU0396/DVU1864 complex. While DVU0396 is active in *E. coli*, the absence of DVU0396 does not significantly impact the expression of the *orp* operon genes in DvH as shown by quantitative RT-PCR. One hypothesis to explain this discrepancy is the large number of HU and IHF proteins in DvH that might have redundant functions. By contrast to the *E. coli* situation, DvH appears to lack the diversity of nucleoid-associated proteins such as Fis or HNS but seems to encode several copies of HU and IHF proteins. DvH genome encodes up to eight DNA-binding HU/ IHF proteins belonging to the COG776 family. Among these, two are annotated as encoding IHFβ-like proteins (DVU1864 and DVU2973, which are 65% identical) and one, DVU1134, is annotated as a true DNA-binding HUβ protein. Whereas DVU1864 and DVU2973 contains a central region extremely well conserved shown to be essential for IHF activity and specificity in *E. coli* [42,43], this central region in DVU1134 is less conserved (Figure 8). Three other HU-like proteins

(DVU0764, DVU1795, DVU3187) exhibit 25-31% sequence identity with DVU0396. All three proteins possess the G62 residue required for IHF activity and possess one additional residue P65 known to be crucial determinants of IHF specificity in *E. coli* [43]. Such redundancy in genes encoding HU/IHF proteins has not been observed in other organisms studied to date. Therefore, although the DVU0396-DVU1864 combination is functionally active in *E. coli* one may hypothesize that distinct homodimers or heterodimers involving different combinations will be used in DvH as previously described in other organisms [21,22,23,24], and therefore the *DVU0396* mutation will not be sufficient to observe an effect on *orp* gene expression in DvH. This hypothesis is strengthened by pull-down experiments demonstrating that DVU1864, while interacting preferentially with DVU0396, is also able to interact with DVU2973, while this later also interacts with DVU0396 and DVU0764 [37]. Further experiments are therefore needed to establish the role of each HU/IHF proteins and identify all functional IHF complexes coexisting in DvH. It would be also interesting to know whether this atypical gene redundancy is linked to the large number of putative EBPs observed in DvH [6].

We recently proposed a model on the regulation of the *orp* operons in which the σ⁵⁴-transcriptional regulator DVU2106 interacts with specific palindromic sequences and collaborates with σ⁵⁴ to activate and synchronize the transcription of the two divergent *orp* operons [6]. DVU2106 is under the control of the housekeeping σ⁷⁰ factor but the overlap between the σ⁷⁰ promoter and the DVU2106-binding sequence creates a negative regulatory loop [6]. With the data presented here, we implemented this model by adding a new player in the game, IHF (Figure 9). We showed that IHF is required for full activity of the *orp1* and *orp2* promoter. As previously suggested, since IHF facilitates DNA bending but does not influence directly the formation of the open complex, its role in σ⁵⁴-dependent systems has to be considered as a co-regulator [44]. In this context, we demonstrated that IHF binds to specific sequences, closely related to the *E. coli* IHF-binding consensus motif, located between the *orp1* and *orp2* σ⁵⁴-promoters and DVU2106 palindromic sites, to co-regulate and orchestrate the simultaneous expression of the divergent *orp* operons. In contrast no effect of IHF was observed on the σ⁷⁰-dependent DVU2106 expression.

## Supporting Information

**Figure S1 Sequences of orp1 (A) and orp2 (B) promoter regions.** The identified σ⁵⁴ promoters of *orp1* and *orp2* are boxed in solid lines. The transcriptional start point of both operons is indicated by bent arrows. The stop codon and the start codon are in italics and underlined, and the shine-Dalgarno are indicated in bold. The two palindromic binding sites of the σ⁵⁴ transcription activator, DVU2106, are boxed in dotted lines. The sequences of the putative IHF-binding sites are in bold and underlined: the *orp1* promoter contains two putative IHF-binding sites and one putative IHF-binding sequence was found in the *orp2* promoter. (PDF)

**Figure S2 Sequences of the different IHF sites and its variants.** Mutated bases are indicated in bold for each mutant variant. These sequences are aligned with the IHF-binding consensus of *E.coli*. (PDF)

**Figure S3 Sequence alignment of each DvH IHF-binding site with IHF-binding site consensus sequences of E.coli (A) and P.putida (B).** (PDF)
**Figure S4** Determination of the consensus sequence of IHF-binding site from the two functional IHF-binding sites in *orp* promoters of *DvH*. This consensus sequence is aligned with the IHF-binding site consensus sequence of *E.coli* and *P.putida*.
(PDF)

**Table S1** Bacterial strains and plasmids used in this study.
(PDF)

**Table S2** Primers used in this study.
(PDF)

References

1. Heidelberg J, Seshadri R, Haveman S, Hemme C, Paulsen I, et al. (2004) The genome sequence of the anaerobic, sulfate-reducing bacterium *Desulfovibrio vulgaris* Hildenborough. Nat Biotechnol 22: 554-559.

2. Zhou J, He Q, Hemme CL, Mukhopadhyay A, Hillesland K, et al. (2011) How sulphate-reducing microorganisms cope with stress: lessons from systems biology. Nat Rev Microbiol 9: 452-66.

3. Hansen TA (1994) Metabolism of sulphate-reducing prokaryotes. Antonie Van Leeuwenhoek 66: 168-185.

4. Muyzer G, Stams AJM (2008) The ecology and biotechnology of sulphate-reducing bacteria. Nature Reviews 6: 441-454.

5. Chhabra SR, He Q, Huang KH, Gaucher SP, Alm EJ, et al. (2006) Global Analysis of Heat Shock Response in *Desulfovibrio vulgaris* Hildenborough. J. Bacteriology 188: 1817-1828.

6. Fièvet A, My L, Cascales E, Ansaldi M, Pauleta SR, et al. (2011) The anaerobe-specific orange protein complex of *Desulfovibrio vulgaris* Hildenborough is encoded by two divergent operons regurgulated by σ⁵⁴ and a cognate transcriptional regulator. J. Bacteriol 193: 3207-3219.

7. Propham DL, Szeto D, Keener J, Kutsu S (1989) Function of a bacterial activator protein that binds to transcriptional enhancers. Science 243: 629-635.

8. Sasse-Dwight S, Gralla JD (1990) Role of eukaryotic-type functional domains found in the prokaryotic enhancer receptor factor sigma 54. Cell 62: 954-954.

9. Studhome DJ, Dixon R (2003) Domain architectures of σ⁵⁴-dependent transcriptional activators. J. Bacteriol 185: 1757-1767.

10. Wedel A, Kutsu S (1995) The bacterial enhancer-binding protein NTRC is a molecular machine: ATP hydrolysis is coupled to transcriptional activation. Genes Dev 9: 2042-2052.

11. Swinger KK, Rice PA (2004) IHF and HU: flexible architects of bent DNA. Curr Opin Struct Biol 14: 28-35.

12. Rice PA, Yang S, Mizuuchi K, Nash HA (1996) Crystal structure of an IHF-DNA complex: a protein-induced DNA U-turn.Cell. 87 : 1295-1306.

13. de Lorenzo V, Herrero M, Metzke M, Timmis KN (1991) An upstream XylR- and IHF-induced nucleoprotein complex regulates the sigma 54-dependent Pu promoter of TOL plasmid. EMBO J 10: 1159-67.

14. Bertoni G, Fujita N, Ishihama A, de Lorenzo V (1998) Active recruitment of sigma54-RNA polymerase to the Pu promoter of *Pseudomonas putida*: role of IHF and alphaGTD. EMBO J 17: 5120-8.

15. Shingler V (2011) Signal sensory systems that impact σ⁵⁴-dependent transcription. FEMS Microbiol Rev 35(3): 425-40.

16. Nash HA, Robertson CA (1981) Purification and properties of the Escherichia coli protein factor required for lambda integrative recombination. J Biol Chem 256: 9246-9253.

17. Dorman CJ (2009) Nucleoid-associated proteins and bacterial physiology. Adv Appl Microbiol 67: 47-64.

18. Arfin SM, Long AD, Ito ET, Tolleri L, Riehle MM, et al. (2000) Global gene expression profiling in *Escherichia coli* K12. The effects of integration host factor. J Biol Chem 275: 29672-29684.

19. Martínez-Antonio A, Collado-Vides J (2003) Identifying global regulators in transcriptional regulatory networks in bacteria. Curr Opin Microbiol 6: 482-489.

20. Schmid MB (1990) More than just “histone-like” proteins. Cell 63: 451-453.

21. Werner MH, Clore GM, Gronenborn AM, Nash HA (1994) Symmetry and asymmetry in the function of *Escherichia coli* integration host factor: implications for target identification by DNA-binding proteins. Curr Biol 4: 477-487.

22. Zulianello L, de la Gorgue de Rosny E, van Ulsen P, van de Putte P, Goosen N (1994) The HimA and HimD subunits of integration host factor can specifically bind to DNA as homodimers. EMBO J 13: 1534-1540.

23. Zablewska B, Kur J (1995) Mutations in HU and IHF affect bacteriophage T4 growth: HimD subunits of IHF appear to function as homodimers. Gene 160: 131-132.

Acknowledgments

We gratefully acknowledge the contribution of Yann Denis for transcrip-
tome facilities and Patrice L. Moreau for the access to the *E. coli* KEIO
collection.

**Author Contributions**

Conceived and designed the experiments: CA EC. Performed the experiments: AF EC OV. Analyzed the data: CA AF EC AD. Contributed reagents/materials/analysis tools: CA AF EC. Wrote the paper: CA EC AF.

24. Hiszczyńska-Sawicka E, Kur J (1998) Effect of integration host factor of RNA II synthesis in replication of plasmid containing oriP 15A. Plasmid 40: 150-157.

25. Hemme CL, Wall JD (2004) Genomic insights into gene regulation of *Desulfovibrio vulgaris* Hildenborough. OMICS 8: 43-55.

26. Postgate J (1966) Media for sulphur bacteria. Lab Pract 15: 1239-1244.

27. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, et al. (2006) Construction of *Escherichia coli* K-12 in-frame, single-gene knockout mutants: Keio collection. Mol Syst Biol 2: 2006-2008.

28. Datsenko KA, Wanner BL. (2000) One-step inactivation of chromosomal genes in *Escherichia coli* K-12 using PCR products. Proc Natl Acad Sci USA 97: 6640-6645.

29. Bernard CS, Brunet YR, Gavioli M, Lloubés R, Cascales E (2011) Regulation of type VI secretion gene clusters by sigma54 and cognate enhancer binding proteins. J Bacteriol. 193: 2158-67.

30. Dolla A, Pohorelic BK, Voordouw JK, Voordouw G (2000) Deletion of the hmc operon of *Desulfovibrio vulgaris* subsp. vulgaris Hildenborough hampers hydrogen metabolism and low-redox-potential niche establishment. Arch Microbiol 74: 143-51.

31. Fournier M, Dermoun Z, Durand MC, Dolla A (2004) A new function of the *Desulfovibrio vulgaris* Hildenborough [Fe] hydrogenase in the protection against oxidative stress. J Biol Chem 79: 1787-93.

32. Miller JH (1975) Experiments in molecular genetics.

33. Murtin C, Engelhorn M, Geiselmann J, Boccard F (1998) A quantitative UV laser footprinting analysis of the interaction of IHF with specific binding sites: re-evaluation of the effective concentration of IHF in the cell. J Mol Biol 284: 949-61.

34. Sidorova NY, Hung S, Rau DC (2010) Stabilizing labile DNA-protein complexes in polyacrylamide gels. Electrophoresis. 31: 648-53.

35. Hales LM, Gumport RI, Gardner JF (1994) Determining the DNA sequence elements required for binding integration host factor to two different target sites. J Bacteriol 176: 2999-3006.

36. Aviv M, Giladi H, Schreiber G, Oppenheim AB, Glaser G (1994) Expression of the genes coding for the Escherichia coli integration host factor are controlled by growth phase, rpoS, ppGpp and by autoregulation.Mol Microbiol 14: 1021-31.

37. Chhabra SR, Butland G, Elias DA, Chandonia JM, Fok OY, et al. (2011) Generalized schemes for high-throughput manipulation of the *Desulfovibrio vulgaris* genome. Appl Environ Microbiol 77: 7595-604.

38. Lacal J, Busch A, Guazzaroni ME, Krell T, Ramos JL (2006) The TodS-TodT two-component regulatory system recognizes a wide range of effectors and works with DNA-bending proteins. Proc Natl Acad Sci U S A 103: 8191-8196.

39. Holcroft CC, Egan SM (2000) Interdependence of activation at rhaSR by cyclic AMP receptor protein, the RNA polymerase alpha subunit C-terminal domain, and rhaR. J Bacteriol 182: 6774-82.

40. Busby S, Ebright RH (1997) Transcription activation at class II CAP-dependent promoters. Mol Microbiol 23: 853-9.

41. Cheema AK, Choudhury NR, Das HK (1999) A- and T-tract-mediated intrinsic curvature in native DNA between the binding site of the upstream activator NtrC and the nifLA promoter of *Klebsiella pneumoniae* facilitates transcription. J Bacteriol 181: 5296-5302.

42. Calb R, Davidovitch A, Koby S, Giladi H, Goldenberg D, et al. (1996) Structure and function of the *Pseudomonas putida* integration host factor. J Bacteriol 178: 6319-26.

43. Lee ECL, Hales M, Gumport RI, Gardner JR (1992) The isolation and characterization of mutants of the integration host factor (IHF) of *Escherichia coli* with altered, expanded DNA-binding specificities. Embo J 11: 305-313.

44. Pérez-Martin J, De Lorenzo V (1997) Coactivation in vitro of the sigma54-dependent promoter Pu of the TOL plasmid of *Pseudomonas putida* by HU and the mammalian HMG-1 protein. J Bacteriol 179: 2757-2760.